New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
MedMen Enterprises Inc.
MMEN.CN
Shape
US Flag

CNQ

Unprofitable

EPS improving

Unprofitable

EPS improving

28M

Drug Manufacturers - Specialty & Generic

0.02CAD
Shape0.01 ( 33.33%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

30%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

60%

Quote Panel

Shape
Updated October 23, 2024
1W % 1M % 3M % 1Y -50.00 %

Key Metrics

Shape
  • Market Cap

    27.66M


  • Shares Outstanding

    1.38B


  • Share in Float


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.02


  • Average Volume

    145639


  • Beta

    1.4


  • Range

    0.015-0.05


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.medmen.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.35x

P/S Ratio

0.16x

P/B Ratio

3.1

Debt/Equity

-81.5%

Net Margin

$-0.1

EPS

How MMEN.CN compares to sector?

P/E Ratio

Relative Strength

Shape

MMEN.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$279M

Shape927%

2023-Revenue

0

$200M

Shape-2782%

2023-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.20

arrow
arrow

N/A

-0.11
vs -0.19

Q1.21

arrow
arrow

N/A

NA
vs NA

Q2.21

arrow
arrow

N/A

-0.06
vs NA

Q3.21

arrow
arrow

N/A

-0.06
vs -0.07

Q4.21

arrow
arrow

N/A

-0.02
vs -0.11

Q1.22

arrow
arrow

N/A

NA
vs NA

Q2.22

arrow
arrow

N/A

-0.02
vs -0.06

Q3.22

arrow
arrow

N/A

-0.02
vs -0.06

Q4.22

arrow
arrow

N/A

-0.03
vs -0.02

Q1.23

arrow
arrow

N/A

NA
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.21

arrow
arrow

+77%

48.7M  vs 27.4M

Q3.21

arrow
arrow

+12%

39.8M  vs 35.6M

Q4.21

arrow
arrow

+16%

39.1M  vs 33.8M

Q1.22

arrow
arrow

+10%

35.2M  vs 32M

Q2.22

arrow
arrow

-32%

33.3M  vs 48.7M

Q3.22

arrow
arrow

-25%

30M  vs 39.8M

Q4.22

arrow
arrow

-24%

29.6M  vs 39.1M

Q1.23

arrow
arrow

-23%

27.2M  vs 35.2M

Q2.23

arrow
arrow

+50%

50.1M  vs 33.3M

Q3.23

arrow
arrow

+67%

50.1M  vs 30M

Return on EquityShape

status-upQoQ

Q2.21

arrow
arrow

-20%

-0.20
vs -0.06

Q3.21

arrow
arrow

-22%

-0.22
vs -0.20

Q4.21

arrow
arrow

-8%

-0.08
vs -0.22

Q1.22

arrow
arrow

-9%

-0.09
vs -0.08

Q2.22

arrow
arrow

-57%

-0.57
vs -0.09

Q3.22

arrow
arrow

-13%

-0.13
vs -0.57

Q4.22

arrow
arrow

-10%

-0.10
vs -0.13

Q1.23

arrow
arrow

-26%

-0.26
vs -0.10

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News